Company involved in various business activities, potentially including real estate and investments.
Fortrea Holdings Inc., a prominent contract research organization (CRO), specializes in providing comprehensive biopharmaceutical product and medical device development services on a global scale. The company operates through two key segments: Clinical Services and Enabling Services. Within the Clinical Services segment, Fortrea offers a broad spectrum of clinical pharmacology and clinical development services. These include phase I-IV clinical trial management, leveraging differentiated technology-enabled trial solutions, and providing post-approval services to its clientele.
In its Enabling Services segment, Fortrea Holdings delivers patient access and clinical trial technology solutions that optimize the complex processes of randomization and trial drug supply. These solutions are designed to enhance efficiency and streamline operations for pharmaceutical, biotechnology, and medical device companies worldwide. The company's service delivery models encompass full service, functional service provider (FSP), and hybrid structures, ensuring flexibility and tailored support to meet diverse client needs.
Founded in 2023 and headquartered in Durham, North Carolina, Fortrea Holdings Inc. continues to expand its capabilities and service offerings in the competitive CRO industry. With a focus on innovation and client satisfaction, Fortrea remains dedicated to advancing healthcare through its specialized expertise in clinical research and development.